← Back to Search

Procedure

Group B for Oncologic Complications and Emergencies

N/A

Recruiting

Led By Jonathan Rowland, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Predetermined to have difficult IV access necessitating USIV placement

Age > 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion; an average of 1 year.

Awards & highlights

Study Summary

This trial aims to understand how the length of a catheter affects the success or failure of placing a USIV.

Who is the study for?

This trial is for adults over 18 who need an IV placed due to hard-to-find veins and are expected to stay in the hospital for more than 48 hours. It's not for those likely to leave soon, unable to consent, pregnant women, or non-English speakers.Check my eligibility

What is being tested?

The study is testing if different lengths of a specific IV catheter (Introcan Safety) affect how well it works when guided by ultrasound in patients with cancer-related emergencies.See study design

What are the potential side effects?

Potential side effects may include discomfort at the insertion site, bruising, infection risk at the catheter entry point into the skin, and rarely complications like a collapsed vein.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need ultrasound-guided IV due to hard-to-find veins.

Select...

I am older than 18 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion; an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion; an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Safety and adverse events (AEs)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group BExperimental Treatment1 Intervention

Participants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.

Group II: Group AExperimental Treatment1 Intervention

Participants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,074 Total Patients Enrolled

Jonathan Rowland, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"According to the information available on clinicaltrials.gov, this particular trial is not currently accepting new patients. Its initial posting was on July 31st, 2024, and it was last updated on January 12th, 2024. However, there are still a total of 197 ongoing clinical trials that are actively seeking participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

2024. "Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06217783.

All > Paid Studies Houston > Paid Studies Pasadena